{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:17:27Z","timestamp":1767968247160,"version":"3.49.0"},"reference-count":159,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Invasive Candida infections in the neonatal intensive care unit (NICU) are associated with significant morbidity and mortality, particularly among extremely preterm neonates. Early treatment with antifungals is critical to improve survival rates and avoid long-term adverse outcomes. Prevention with antifungal prophylaxis in high-risk neonates has been shown to reduce the prevalence of invasive Candida infections effectively. However, the irrational and\/or inappropriate use of antifungals has been documented. This narrative review aims to provide an overview of the rationales for the inappropriate use of antifungals in the NICU, the consequences that ensue, and the promising strategy of antifungal stewardship programs to optimize antifungal use. The nonspecific clinical presentation of systemic Candida infections and the lack of rapid, accurate diagnostic techniques for Candida identification and specification in most settings lead to a high rate of empirical treatment in neonates without a proven infection. Moreover, evidence on the optimal dosing of antifungal agents and the treatment duration in the neonatal population is lacking, which may result in excessive or subtherapeutic drug exposure. Antifungal misuse is associated with microbiological consequences, including the emergence of antifungal-resistant Candida strains, and clinical consequences, such as drug toxicities and alterations in the intestinal mycobiome. It is therefore imperative to optimize antifungal use in the NICU. The implementation of antifungal stewardship programs, which, through a multidisciplinary approach, aim to improve diagnosis and guide clinicians on antifungal selection, dosing, and duration for both prevention and treatment according to the local epidemiology, represents a promising strategy for antifungal optimization in the NICU.<\/jats:p>","DOI":"10.3390\/antibiotics15010073","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T11:45:33Z","timestamp":1767959133000},"page":"73","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Irrational and Inappropriate Use of Antifungals in the NICU: A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7287-7401","authenticated-orcid":false,"given":"Niki","family":"Dermitzaki","sequence":"first","affiliation":[{"name":"Neonatal Intensive Care Unit, School of Medicine, University of Ioannina, 45500 Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0967-8673","authenticated-orcid":false,"given":"Foteini","family":"Balomenou","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, School of Medicine, University of Ioannina, 45500 Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1244-375X","authenticated-orcid":false,"given":"Chrysoula","family":"Kosmeri","sequence":"additional","affiliation":[{"name":"Pediatric Department, School of Medicine, University of Ioannina, 45500 Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Baltogianni","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, School of Medicine, University of Ioannina, 45500 Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9065-7971","authenticated-orcid":false,"given":"Aikaterini","family":"Nikolaou","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, School of Medicine, University of Ioannina, 45500 Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5422-3988","authenticated-orcid":false,"given":"Anastasios","family":"Serbis","sequence":"additional","affiliation":[{"name":"Pediatric Department, School of Medicine, University of Ioannina, 45500 Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Giapros","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, School of Medicine, University of Ioannina, 45500 Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kariniotaki, C., Thomou, C., Gkentzi, D., Panteris, E., Dimitriou, G., and Hatzidaki, E. (2024). Neonatal Sepsis: A Comprehensive Review. Antibiotics, 14.","DOI":"10.3390\/antibiotics14010006"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/INF.0000000000004485","article-title":"Beyond Early- and Late-Onset Neonatal Sepsis Definitions: What Are the Current Causes of Neonatal Sepsis Globally? A Systematic Review and Meta-Analysis of the Evidence","volume":"43","author":"Harrison","year":"2024","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e2022058813","DOI":"10.1542\/peds.2022-058813","article-title":"Late-Onset Sepsis Among Very Preterm Infants","volume":"150","author":"Flannery","year":"2022","journal-title":"Pediatrics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"ofaf329","DOI":"10.1093\/ofid\/ofaf329","article-title":"The Burden of Neonatal Invasive Candidiasis in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis","volume":"12","author":"Tsai","year":"2025","journal-title":"Open Forum Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.clp.2014.10.008","article-title":"The Epidemiology and Diagnosis of Invasive Candidiasis Among Premature Infants","volume":"42","author":"Kelly","year":"2015","journal-title":"Clin. Perinatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/INF.0000000000001968","article-title":"Invasive Fungal Infections in Neonates in Canada","volume":"37","author":"Ting","year":"2018","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/INF.0000000000001913","article-title":"Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis","volume":"37","author":"Autmizguine","year":"2018","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Barton, M., O\u2019Brien, K., Robinson, J.L., Davies, D.H., Simpson, K., Asztalos, E., Langley, J.M., Le Saux, N., Sauve, R., and Synnes, A. (2014). Invasive Candidiasis in Low Birth Weight Preterm Infants: Risk Factors, Clinical Course and Outcome in a Prospective Multicenter Study of Cases and Their Matched Controls. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-327"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1542\/peds.2004-2292","article-title":"Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months","volume":"117","author":"Benjamin","year":"2006","journal-title":"Pediatrics"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Zhou, Q., Kelly, E., Luu, T.M., Ye, X.Y., Ting, J., Shah, P.S., and Lee, S.K. (2023). Fungal Infection and Neurodevelopmental Outcomes at 18\u201330 Months in Preterm Infants. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1145252"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"myad010","DOI":"10.1093\/mmy\/myad010","article-title":"Neonatal Invasive Candidiasis in Low- and Middle-Income Countries: Data from the NeoOBS Study","volume":"61","author":"Cook","year":"2023","journal-title":"Med. Mycol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Jajoo, M., Manchanda, V., Chaurasia, S., Sankar, M.J., Gautam, H., Agarwal, R., Yadav, C.P., Aggarwal, K.C., Chellani, H., and Ramji, S. (2018). Alarming Rates of Antimicrobial Resistance and Fungal Sepsis in Outborn Neonates in North India. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0180705"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/INF.0000000000002530","article-title":"Etiology and Outcome of Candidemia in Neonates and Children in Europe","volume":"39","author":"Warris","year":"2020","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s12098-025-05593-9","article-title":"Neonatal Invasive Candidiasis: Current Concepts","volume":"92","author":"Chowdhary","year":"2025","journal-title":"Indian. J. Pediatr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"F188","DOI":"10.1136\/adc.2005.082024","article-title":"Invasive Fungal Infection in Very Low Birthweight Infants: National Prospective Surveillance Study","volume":"91","author":"Clerihew","year":"2006","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/myc.13145","article-title":"Characteristics, Outcome and Risk Factors for Mortality of Paediatric Patients with ICU-acquired Candidemia in India: A Multicentre Prospective Study","volume":"63","author":"Chakrabarti","year":"2020","journal-title":"Mycoses"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1093\/jpids\/piy009","article-title":"Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009\u20132015","volume":"7","author":"Benedict","year":"2018","journal-title":"J. Pediatric. Infect. Dis. Soc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1517\/14656566.2012.647685","article-title":"Invasive Fungal Infections during the Neonatal Period: Diagnosis, Treatment and Prophylaxis","volume":"13","author":"Tezer","year":"2012","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41390-021-01842-7","article-title":"Invasive Fungal Infections in Neonates: A Review","volume":"91","author":"Weimer","year":"2022","journal-title":"Pediatr. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S2352-4642(21)00272-8","article-title":"Neonatal Invasive Candidiasis: Updates on Clinical Management and Prevention","volume":"6","author":"Kilpatrick","year":"2022","journal-title":"Lancet Child. Adolesc. Health"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1542\/peds.112.3.634","article-title":"Neonatal Candidemia and End-Organ Damage: A Critical Appraisal of the Literature Using Meta-Analytic Techniques","volume":"112","author":"Benjamin","year":"2003","journal-title":"Pediatrics"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Han, T., Qiu, M., Niu, X., Wang, S., Wang, F., Cao, J., Tang, S., Cheng, L., Mei, Y., and Liang, H. (2024). End-Organ Damage from Neonatal Invasive Fungal Infection: A 14-Year Retrospective Study from a Tertiary Center in China. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-09360-7"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Camp, I., Spettel, K., and Willinger, B. (2020). Molecular Methods for the Diagnosis of Invasive Candidiasis. J. Fungi, 6.","DOI":"10.3390\/jof6030101"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"He, B., and Yang, Q. (2023). Updates in Laboratory Identification of Invasive Fungal Infection in Neonates. Microorganisms, 11.","DOI":"10.3390\/microorganisms11041001"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jped.2023.11.005","article-title":"Epidemiological Indicators and Predictors of Lethality Associated with Fungal Infections in a NICU: A Historical Series","volume":"100","author":"Lopes","year":"2024","journal-title":"J. Pediatr."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Dermitzaki, N., Baltogianni, M., Tsekoura, E., and Giapros, V. (2024). Invasive Candida Infections in Neonatal Intensive Care Units: Risk Factors and New Insights in Prevention. Pathogens, 13.","DOI":"10.20944\/preprints202407.0540.v1"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jhin.2023.01.002","article-title":"Invasive Fungal Infection Is Associated with Antibiotic Exposure in Preterm Infants: A Multi-Centre Prospective Case\u2013Control Study","volume":"134","author":"Hou","year":"2023","journal-title":"J. Hosp. Infect."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpeds.2005.02.021","article-title":"Risk Factors for Candidemia in Critically Ill Infants: A Matched Case-Control Study","volume":"147","author":"Feja","year":"2005","journal-title":"J. Pediatr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/sj.jp.7210699","article-title":"Dexamethasone Therapy and Candida Sepsis in Neonates Less Than 1250 Grams","volume":"22","author":"Pera","year":"2002","journal-title":"J. Perinatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/INF.0000000000004445","article-title":"Antifungal Drug Usage in European Neonatal Units: A Multicenter Weekly Point Prevalence Study","volume":"43","author":"Chorafa","year":"2024","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID Guideline for the Diagnosis and Management of Candida Diseases 2012: Prevention and Management of Invasive Infections in Neonates and Children Caused by Candida spp.","volume":"18","author":"Hope","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/17425255.2020.1773793","article-title":"Pharmacokinetic, Efficacy, and Safety Considerations for the Use of Antifungal Drugs in the Neonatal Population","volume":"16","author":"Scott","year":"2020","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_34","first-page":"114","article-title":"Review of Amphotericin B for Invasive Fungal Infections in Neonates and Children","volume":"2","author":"Unni","year":"2020","journal-title":"Pediatr. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/INF.0b013e3181af6201","article-title":"Nephrotoxicity Associated with Amphotericin B Deoxycholate in Neonates","volume":"28","author":"Le","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/bcp.13521","article-title":"Adverse Effects of Amphotericin B in Children; a Retrospective Comparison of Conventional and Liposomal Formulations","volume":"84","author":"Andrew","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40272-020-00379-2","article-title":"Administration and Dosing of Systemic Antifungal Agents in Pediatric Patients","volume":"22","author":"Downes","year":"2020","journal-title":"Pediatr. Drugs"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Baltogianni, M., Giapros, V., and Dermitzaki, N. (2024). Recent Challenges in Diagnosis and Treatment of Invasive Candidiasis in Neonates. Children, 11.","DOI":"10.20944\/preprints202408.1064.v1"},{"key":"ref_39","first-page":"115","article-title":"Review of Fluconazole Treatment and Prophylaxis for Invasive Candidiasis in Neonates","volume":"26","author":"Hornik","year":"2021","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Bersani, I., Piersigilli, F., Goffredo, B.M., Santisi, A., Cairoli, S., Ronchetti, M.P., and Auriti, C. (2019). Antifungal Drugs for Invasive Candida Infections (ICI) in Neonates: Future Perspectives. Front. Pediatr., 7.","DOI":"10.3389\/fped.2019.00375"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3201\/eid2703.203482","article-title":"Fluconazole-Resistant Candida Glabrata Bloodstream Isolates, South Korea, 2008\u20132018","volume":"27","author":"Won","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Mroczy\u0144ska, M., and Brillowska-D\u0105browska, A. (2020). Review on Current Status of Echinocandins Use. Antibiotics, 9.","DOI":"10.3390\/antibiotics9050227"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/11585270-000000000-00000","article-title":"Echinocandin Antifungal Drugs in Fungal Infections","volume":"71","author":"Chen","year":"2011","journal-title":"Drugs"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"myae065","DOI":"10.1093\/mmy\/myae065","article-title":"Comparative Efficacies of the Three Echinocandins for Candida Auris Candidemia: Real World Evidence from a Tertiary Centre in India","volume":"62","author":"Prayag","year":"2024","journal-title":"Med. Mycol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jac\/dkz398","article-title":"A Randomized, Double-Blind Trial Investigating the Efficacy of Caspofungin versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants Younger than 3\u2009Months of Age","volume":"75","author":"Kim","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1097\/INF.0000000000000434","article-title":"Micafungin in Premature and Non-Premature Infants","volume":"33","author":"Manzoni","year":"2014","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-2008-1063859","article-title":"Update on Echinocandin Antifungals","volume":"29","author":"Kauffman","year":"2008","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/INF.0000000000002032","article-title":"Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children","volume":"38","author":"Tsekoura","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_49","unstructured":"(2025, September 17). Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/mycamine-epar-product-information_en.pdf."},{"key":"ref_50","unstructured":"(2025, September 17). Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/021506s023lbl.pdf."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Agudelo-P\u00e9rez, S., Fern\u00e1ndez-Sarmiento, J., Rivera Le\u00f3n, D., and Pel\u00e1ez, R.G. (2023). Metagenomics by Next-Generation Sequencing (MNGS) in the Etiological Characterization of Neonatal and Pediatric Sepsis: A Systematic Review. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1011723"},{"key":"ref_52","first-page":"20499361231161387","article-title":"Flucytosine and Its Clinical Usage","volume":"10","author":"Sigera","year":"2023","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/INF.0000000000002463","article-title":"Neonatal Antifungal Consumption Is Dominated by Prophylactic Use; Outcomes From The Pediatric Antifungal Stewardship: Optimizing Antifungal Prescription Study","volume":"38","author":"Irwin","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/INF.0000000000002001","article-title":"Antifungal Treatment and Outcome in Very Low Birth Weight Infants","volume":"37","author":"Fortmann","year":"2018","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1097\/INF.0000000000003967","article-title":"Antifungal Stewardship Programs in Children: Challenges and Opportunities","volume":"42","author":"Kourti","year":"2023","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0022-3476(88)80653-X","article-title":"Pharmacokinetics and Adverse Effects of Amphotericin B in Infants and Children","volume":"113","author":"Koren","year":"1988","journal-title":"J. Pediatr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1086\/367933","article-title":"Voriconazole: A New Triazole Antifungal Agent","volume":"36","author":"Johnson","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Dermitzaki, N., Balomenou, F., Gialamprinou, D., Giapros, V., Rallis, D., and Baltogianni, M. (2024). Perspectives on the Use of Echinocandins in the Neonatal Intensive Care Unit. Antibiotics, 13.","DOI":"10.20944\/preprints202411.0926.v1"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/imj.15589","article-title":"Consensus Guidelines for the Diagnosis and Management of Invasive Candidiasis in Haematology, Oncology and Intensive Care Settings, 2021","volume":"51","author":"Keighley","year":"2021","journal-title":"Intern. Med. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1128\/JCM.01706-15","article-title":"Blood Volume Required for Detection of Low Levels and Ultralow Levels of Organisms Responsible for Neonatal Bacteremia by Use of Bactec Peds Plus\/F, Plus Aerobic\/F Medium, and the BD Bactec FX System: An In Vitro Study","volume":"53","author":"Lancaster","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1067\/mpd.2003.188","article-title":"Time to Positive Culture Results in Neonatal Candida Septicemia","volume":"142","author":"Schelonka","year":"2003","journal-title":"J. Pediatr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/apa.15321","article-title":"Serum (1 \u2192 3)-\u03b2-D-glucan Could Be Useful to Rule out Invasive Candidiasis in Neonates with an Adapted Cut-off","volume":"110","author":"Cliquennois","year":"2021","journal-title":"Acta Paediatr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cmi.2019.09.010","article-title":"Diagnostic Accuracy of Serum (1,3)-Beta-d-Glucan for Neonatal Invasive Candidiasis: Systematic Review and Meta-Analysis","volume":"26","author":"Cohen","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_64","first-page":"125","article-title":"Invasive Fungal Infections in Neonatal Intensive Care Units of Southern Italy: A Multicentre Regional Active Surveillance (AURORA Project)","volume":"51","author":"Montagna","year":"2010","journal-title":"J. Prev. Med. Hyg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1469-0691.2007.01938.x","article-title":"Experience with the Platelia Candida ELISA for the Diagnosis of Invasive Candidosis in Neonatal Patients","volume":"14","author":"Oliveri","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/jpids\/pix054","article-title":"Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children","volume":"6","author":"Huppler","year":"2017","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1542\/peds.2013-0671","article-title":"Changes in the Incidence of Candidiasis in Neonatal Intensive Care Units","volume":"133","author":"Aliaga","year":"2014","journal-title":"Pediatrics"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/INF.0000000000003402","article-title":"Pediatric Antifungal Prescribing Patterns Identify Significant Opportunities to Rationalize Antifungal Use in Children","volume":"41","author":"Irwin","year":"2022","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/INF.0000000000002983","article-title":"Global Divergence of Antifungal Prescribing Patterns","volume":"40","author":"Bielicki","year":"2021","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/INF.0000000000002317","article-title":"Management of Invasive Fungal Disease in Neonates and Children","volume":"38","author":"Sharland","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"De Rose, D.U., Ronchetti, M.P., Santisi, A., Bernaschi, P., Martini, L., Porzio, O., Dotta, A., and Auriti, C. (2024). Stop in Time: How to Reduce Unnecessary Antibiotics in Newborns with Late-Onset Sepsis in Neonatal Intensive Care. Trop. Med. Infect. Dis., 9.","DOI":"10.3390\/tropicalmed9030063"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/jpids\/piy043","article-title":"Antibiotic Stewardship in the Neonatal Intensive Care Unit: Effects of an Automatic 48-Hour Antibiotic Stop Order on Antibiotic Use","volume":"8","author":"Astorga","year":"2019","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Dermitzaki, N., Atzemoglou, N., Giapros, V., Baltogianni, M., Rallis, D., Gouvias, T., Serbis, A., and Drougia, A. (2025). Elimination of Candida Sepsis and Reducing Several Morbidities in a Tertiary NICU in Greece After Changing Antibiotic, Ventilation, and Nutrition Protocols. Antibiotics, 14.","DOI":"10.20944\/preprints202501.1262.v1"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/bcp.12025","article-title":"Antifungal Agents and Therapy for Infants and Children with Invasive Fungal Infections: A Pharmacological Perspective","volume":"75","author":"Lestner","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/AAC.04109-14","article-title":"Systemic Antifungal Prescribing in Neonates and Children: Outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study","volume":"59","author":"Lestner","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/bcp.13628","article-title":"Pharmacokinetics and Safety of Fluconazole and Micafungin in Neonates with Systemic Candidiasis: A Randomized, Open-label Clinical Trial","volume":"84","author":"Leroux","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global Guideline for the Diagnosis and Management of Candidiasis: An Initiative of the ECMM in Cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"De Rose, D., Bersani, I., Ronchetti, M., Piersigilli, F., Cairoli, S., Dotta, A., Desai, A., Kovanda, L., Goffredo, B., and Auriti, C. (2023). Plasma and Cerebrospinal Fluid Concentrations of Micafungin Administered at High Doses in Critically Ill Infants with Systemic Candidiasis: A Pooled Analysis of Two Studies. Pharmaceuticals, 16.","DOI":"10.3390\/ph16030472"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/INF.0b013e3181910e2d","article-title":"Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates","volume":"28","author":"Smith","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/14787210.2020.1794817","article-title":"Caspofungin: A Review of Its Characteristics, Activity, and Use in Intensive Care Units","volume":"18","author":"Hashemian","year":"2020","journal-title":"Expert. Rev. Anti Infect. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Iosifidis, E., Papachristou, S., and Roilides, E. (2018). Advances in the Treatment of Mycoses in Pediatric Patients. J. Fungi, 4.","DOI":"10.3390\/jof4040115"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Ferrando, G., and Castagnola, E. (2023). Prophylaxis of Invasive Fungal Infection in Neonates: A Narrative Review for Practical Purposes. J. Fungi, 9.","DOI":"10.3390\/jof9020164"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3345\/cep.2019.01431","article-title":"Fluconazole Prophylaxis against Invasive Candidiasis in Very Low and Extremely Low Birth Weight Preterm Neonates: A Systematic Review and Meta-Analysis","volume":"64","year":"2021","journal-title":"Clin. Exp. Pediatr."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/cid\/ciw363","article-title":"Fluconazole Prophylaxis for the Prevention of Candidiasis in Premature Infants: A Meta-Analysis Using Patient-Level Data","volume":"63","author":"Ericson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Zhang, D., Xie, D., He, N., Wang, X., Dong, W., and Lei, X. (2021). Prophylactic Use of Fluconazole in Very Premature Infants. Front. Pediatr., 9.","DOI":"10.3389\/fped.2021.726769"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1097\/pq9.0000000000000579","article-title":"A Quality Improvement Project Aimed at Standardizing the Prescribing of Fluconazole Prophylaxis in a Level IV Neonatal Intensive Care Unit","volume":"7","author":"Smith","year":"2022","journal-title":"Pediatr. Qual. Saf."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.jp.7211914","article-title":"Fluconazole Prophylaxis for Prevention of Invasive Fungal Infections in Targeted Highest Risk Preterm Infants Limits Drug Exposure","volume":"28","author":"Weitkamp","year":"2008","journal-title":"J. Perinatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jpeds.2017.02.039","article-title":"Fluconazole Doses Used for Prophylaxis of Invasive Fungal Infection in Neonatal Intensive Care Units: A Network Meta-Analysis","volume":"185","author":"Leonart","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1128\/AAC.00963-16","article-title":"Population Pharmacokinetics of Fluconazole in Premature Infants with Birth Weights Less than 750 Grams","volume":"60","author":"Momper","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/INF.0b013e31819f1f50","article-title":"Fluconazole Dosing for the Prevention or Treatment of Invasive Candidiasis in Young Infants","volume":"28","author":"Wade","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Chen, J., Jiang, Y., Wei, B., Ding, Y., Xu, S., Qin, P., and Fu, J. (2016). Epidemiology of and Risk Factors for Neonatal Candidemia at a Tertiary Care Hospital in Western China. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-2042-9"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00431-011-1565-8","article-title":"European Survey on the Use of Prophylactic Fluconazole in Neonatal Intensive Care Units","volume":"171","author":"Kaguelidou","year":"2012","journal-title":"Eur. J. Pediatr."},{"key":"ref_93","first-page":"e28345","article-title":"Oral Nystatin Prophylaxis for the Prevention of Fungal Colonization in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"14","author":"Almahmoud","year":"2022","journal-title":"Cureus"},{"key":"ref_94","first-page":"CD003478","article-title":"Prophylactic Oral\/Topical Non-Absorbed Antifungal Agents to Prevent Invasive Fungal Infection in Very Low Birth Weight Infants","volume":"2015","author":"Austin","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/jpc.15019","article-title":"Neonatal Candida Auris Infection: Management and Prevention Strategies\u2014A Single Centre Experience","volume":"56","author":"Chandramati","year":"2020","journal-title":"J. Paediatr. Child. Health"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/524071","article-title":"Resistance to Antifungal Agents: Mechanisms and Clinical Impact","volume":"46","author":"Kanafani","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3390\/encyclopedia2040118","article-title":"Antifungals and Drug Resistance","volume":"2","author":"Hossain","year":"2022","journal-title":"Encyclopedia"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the Emerging Threat of Antifungal Resistance to Human Health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Vitiello, A., Ferrara, F., Boccellino, M., Ponzo, A., Cimmino, C., Comberiati, E., Zovi, A., Clemente, S., and Sabbatucci, M. (2023). Antifungal Drug Resistance: An Emergent Health Threat. Biomedicines, 11.","DOI":"10.3390\/biomedicines11041063"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s42770-023-00943-1","article-title":"Candidemia in Brazilian Neonatal Intensive Care Units: Risk Factors, Epidemiology, and Antifungal Resistance","volume":"54","author":"Amorim","year":"2023","journal-title":"Braz. J. Microbiol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Noni, M., Stathi, A., Vaki, I., Velegraki, A., Zachariadou, L., and Michos, A. (2019). Changing Epidemiology of Invasive Candidiasis in Children during a 10-Year Period. J. Fungi, 5.","DOI":"10.3390\/jof5010019"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11046-025-01022-9","article-title":"Trends in Pediatric Invasive Candidiasis: Shifting Species Distribution and Improving Outcomes","volume":"190","author":"Aykac","year":"2025","journal-title":"Mycopathologia"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1093\/jac\/dky353","article-title":"Effect of Fluconazole Prophylaxis on Candida Fluconazole Susceptibility in Premature Infants","volume":"73","author":"Autmizguine","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1055\/s-0039-1691808","article-title":"Fungal Ecology in a Tertiary Neonatal Intensive Care Unit after 16 Years of Routine Fluconazole Prophylaxis: No Emergence of Native Fluconazole-Resistant Strains","volume":"36","author":"Luparia","year":"2019","journal-title":"Am. J. Perinatol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1128\/AAC.01053-05","article-title":"Impact of Antimicrobial Dosing Regimen on Evolution of Drug Resistance In Vivo: Fluconazole and Candida Albicans","volume":"50","author":"Andes","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1542\/peds.2004-2227","article-title":"Prophylactic Fluconazole Is Effective in Preventing Fungal Colonization and Fungal Systemic Infections in Preterm Neonates: A Single-Center, 6-Year, Retrospective Cohort Study","volume":"117","author":"Manzoni","year":"2006","journal-title":"Pediatrics"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa010494","article-title":"Fluconazole Prophylaxis against Fungal Colonization and Infection in Preterm Infants","volume":"34","author":"Kaufman","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1542\/peds.2007-1130","article-title":"Fluconazole Prophylaxis in Extremely Low Birth Weight Neonates Reduces Invasive Candidiasis Mortality Rates Without Emergence of Fluconazole-Resistant Candida Species","volume":"121","author":"Healy","year":"2008","journal-title":"Pediatrics"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1128\/JCM.43.6.2729-2735.2005","article-title":"Emergence of Fluconazole Resistance in a Candida Parapsilosis Strain That Caused Infections in a Neonatal Intensive Care Unit","volume":"43","author":"Sarvikivi","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Lee, J., Kim, H.-S., Shin, S.H., Choi, C.W., Kim, E.-K., Choi, E.H., Kim, B.I., and Choi, J.-H. (2016). Efficacy and Safety of Fluconazole Prophylaxis in Extremely Low Birth Weight Infants: Multicenter Pre-Post Cohort Study. BMC Pediatr., 16.","DOI":"10.1186\/s12887-016-0605-y"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Sokou, R., Palioura, A.E., Kopanou Taliaka, P., Konstantinidi, A., Tsantes, A.G., Piovani, D., Tsante, K.A., Gounari, E.A., Iliodromiti, Z., and Boutsikou, T. (2024). Candida Auris Infection, a Rapidly Emerging Threat in the Neonatal Intensive Care Units: A Systematic Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13061586"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrmicro.2017.107","article-title":"Development and Regulation of Single- and Multi-Species Candida Albicans Biofilms","volume":"16","author":"Lohse","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Amann, V., Kissmann, A.-K., Firacative, C., and Rosenau, F. (2025). Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options. Pharmaceuticals, 18.","DOI":"10.3390\/ph18040460"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Cavalheiro, M., and Teixeira, M.C. (2018). Candida Biofilms: Threats, Challenges, and Promising Strategies. Front. Med., 5.","DOI":"10.3389\/fmed.2018.00028"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1128\/IAI.71.8.4333-4340.2003","article-title":"Mechanism of Fluconazole Resistance in Candida Albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols","volume":"71","author":"Mukherjee","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1128\/AAC.00684-06","article-title":"Candida Albicans Biofilms Produce Antifungal-Tolerant Persister Cells","volume":"50","author":"LaFleur","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"260","DOI":"10.20411\/pai.v4i2.291","article-title":"Environmental Contamination with Candida Species in Multiple Hospitals Including a Tertiary Care Hospital with a Candida Auris Outbreak","volume":"4","author":"Kumar","year":"2019","journal-title":"Pathog. Immun."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jhin.2023.04.007","article-title":"Survival of Candida Auris on Environmental Surface Materials and Low-Level Resistance to Disinfectant","volume":"137","author":"Dire","year":"2023","journal-title":"J. Hosp. Infect."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s42770-020-00232-1","article-title":"Candidemia by Candida Parapsilosis in a Neonatal Intensive Care Unit: Human and Environmental Reservoirs, Virulence Factors, and Antifungal Susceptibility","volume":"51","author":"Bessa","year":"2020","journal-title":"Braz. J. Microbiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/myc.13445","article-title":"Expert Recommendations for Prevention and Management of Candida Auris Transmission","volume":"65","author":"Aldejohann","year":"2022","journal-title":"Mycoses"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Miyake, A., Gotoh, K., Iwahashi, J., Togo, A., Horita, R., Miura, M., Kinoshita, M., Ohta, K., Yamashita, Y., and Watanabe, H. (2022). Characteristics of Biofilms Formed by C. Parapsilosis Causing an Outbreak in a Neonatal Intensive Care Unit. J. Fungi, 8.","DOI":"10.3390\/jof8070700"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.3201\/eid2910.230181","article-title":"Candida Auris Clinical Isolates Associated with Outbreak in Neonatal Unit of Tertiary Academic Hospital, South Africa","volume":"29","author":"Kekana","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/jpids\/piaa152","article-title":"A Cluster of Neonatal Infections Caused by Candida Auris at a Large Referral Center in Colombia","volume":"10","year":"2021","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1017\/ash.2024.77","article-title":"A Cluster of Candida Parapsilosis Displaying Fluconazole-Trailing in a Neonatal Intensive Care Unit Successfully Contained by Multiple Infection-Control Interventions","volume":"4","author":"Baba","year":"2024","journal-title":"Antimicrob. Steward. Healthc. Epidemiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0022-3476(05)82674-5","article-title":"Pharmacokinetics, Outcome of Treatment, and Toxic Effects of Amphotericin B and 5-Fluorocytosine in Neonates","volume":"116","author":"Baley","year":"1990","journal-title":"J. Pediatr."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00228-012-1468-2","article-title":"Safety of Fluconazole in Paediatrics: A Systematic Review","volume":"69","author":"Egunsola","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/INF.0b013e31824acc33","article-title":"Therapeutic Monitoring of Voriconazole in Children Less Than Three Years of Age","volume":"31","author":"Doby","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/INF.0000000000002568","article-title":"Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia","volume":"39","author":"Roilides","year":"2020","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Dobrek, L. (2023). A Synopsis of Current Theories on Drug-Induced Nephrotoxicity. Life, 13.","DOI":"10.3390\/life13020325"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Yao, Y., Cai, X., Ye, Y., Wang, F., Chen, F., and Zheng, C. (2021). The Role of Microbiota in Infant Health: From Early Life to Adulthood. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.708472"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e969","DOI":"10.1016\/S2666-5247(22)00203-8","article-title":"The Gut Mycobiome in Health, Disease, and Clinical Applications in Association with the Gut Bacterial Microbiome Assembly","volume":"3","author":"Zhang","year":"2022","journal-title":"Lancet Microbe"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Wojciechowska, D., Salamon, S., and Wr\u00f3blewska-Seniuk, K. (2024). It\u2019s Time to Shed Some Light on the Importance of Fungi in Neonatal Intensive Care Units: What Do We Know about the Neonatal Mycobiome?. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1355418"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e70168","DOI":"10.1002\/mco2.70168","article-title":"Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy","volume":"6","author":"Shen","year":"2025","journal-title":"MedComm"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"James, S.A., Phillips, S., Telatin, A., Baker, D., Ansorge, R., Clarke, P., Hall, L.J., and Carding, S.R. (2020). Preterm Infants Harbour a Rapidly Changing Mycobiota That Includes Candida Pathobionts. J. Fungi, 6.","DOI":"10.3390\/jof6040273"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Mpakosi, A., Sokou, R., Theodoraki, M., and Kaliouli-Antonopoulou, C. (2024). Neonatal Gut Mycobiome: Immunity, Diversity of Fungal Strains, and Individual and Non-Individual Factors. Life, 14.","DOI":"10.3390\/life14070902"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.chom.2016.05.003","article-title":"Immunological Consequences of Intestinal Fungal Dysbiosis","volume":"19","author":"Wheeler","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Boutin, R.C.T., Sbihi, H., McLaughlin, R.J., Hahn, A.S., Konwar, K.M., Loo, R.S., Dai, D., Petersen, C., Brinkman, F.S.L., and Winsor, G.L. (2021). Composition and Associations of the Infant Gut Fungal Microbiota with Environmental Factors and Childhood Allergic Outcomes. mBio, 12.","DOI":"10.1128\/mBio.03396-20"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2440111","DOI":"10.1080\/19490976.2024.2440111","article-title":"The Mycobiome as Integral Part of the Gut Microbiome: Crucial Role of Symbiotic Fungi in Health and Disease","volume":"16","author":"Huang","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.immuni.2019.05.023","article-title":"Gut Mycobiota in Immunity and Inflammatory Disease","volume":"50","author":"Li","year":"2019","journal-title":"Immunity"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"100185","DOI":"10.1016\/j.advnut.2024.100185","article-title":"The Role of Early Life Gut Mycobiome on Child Health","volume":"15","author":"Rodriguez","year":"2024","journal-title":"Adv. Nutr."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13223-016-0173-6","article-title":"Asthma and the Microbiome: Defining the Critical Window in Early Life","volume":"13","author":"Stiemsma","year":"2017","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm.4176","article-title":"Neonatal Gut Microbiota Associates with Childhood Multisensitized Atopy and T Cell Differentiation","volume":"22","author":"Fujimura","year":"2016","journal-title":"Nat. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaci.2017.08.041","article-title":"Associations between Infant Fungal and Bacterial Dysbiosis and Childhood Atopic Wheeze in a Nonindustrialized Setting","volume":"142","author":"Arrieta","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Schei, K., Simpson, M.R., Avershina, E., Rudi, K., \u00d8ien, T., J\u00fal\u00edusson, P.B., Underhill, D., Salamati, S., and \u00d8deg\u00e5rd, R.A. (2020). Early Gut Fungal and Bacterial Microbiota and Childhood Growth. Front. Pediatr., 8.","DOI":"10.3389\/fped.2020.572538"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"100928","DOI":"10.1016\/j.xcrm.2023.100928","article-title":"Maturational Patterns of the Infant Gut Mycobiome Are Associated with Early-Life Body Mass Index","volume":"4","author":"Gutierrez","year":"2023","journal-title":"Cell Rep. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1089\/chi.2015.0194","article-title":"Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study","volume":"13","author":"Borgo","year":"2017","journal-title":"Child. Obes."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Carrillo-Serradell, L., Liu-Tindall, J., Planells-Romeo, V., Arag\u00f3n-Serrano, L., Isamat, M., Gabald\u00f3n, T., Lozano, F., and Velasco-de Andr\u00e9s, M. (2025). The Human Mycobiome: Composition, Immune Interactions, and Impact on Disease. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157281"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Wei, X., Guo, Z., Wang, J., Gao, D., Xu, Q., and Hua, S. (2025). Gut Mycobiome in Cardiometabolic Disease Progression: Current Evidence and Future Directions. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1659654"},{"key":"ref_149","first-page":"207","article-title":"The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges","volume":"185","author":"Tiew","year":"2020","journal-title":"Mycopathologia"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"dlae119","DOI":"10.1093\/jacamr\/dlae119","article-title":"Promoting Antifungal Stewardship through an Antifungal Multidisciplinary Team in a Paediatric and Adult Tertiary Centre in the UK","volume":"6","author":"Soni","year":"2024","journal-title":"JAC Antimicrob. Resist."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jgar.2019.05.030","article-title":"Antifungal Stewardship with an Emphasis on Candidaemia","volume":"19","author":"Capoor","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"106255","DOI":"10.1016\/j.ijantimicag.2020.106255","article-title":"Impact of a Non-Compulsory Antifungal Stewardship Program on Overuse and Misuse of Antifungal Agents in a Tertiary Care Hospital","volume":"57","author":"Markogiannakis","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Albahar, F., Alhamad, H., Abu Assab, M., Abu-Farha, R., Alawi, L., and Khaleel, S. (2023). The Impact of Antifungal Stewardship on Clinical and Performance Measures: A Global Systematic Review. Trop. Med. Infect. Dis., 9.","DOI":"10.3390\/tropicalmed9010008"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/INF.0b013e3181e9dea2","article-title":"Impact of routine fluconazole prophylaxis for premature infants with birth weights of less than 1250 grams in a developing country","volume":"29","author":"Rueda","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1542\/peds.2005-1969","article-title":"Targeted Short-Term Fluconazole Prophylaxis Among Very Low Birth Weight and Extremely Low Birth Weight Infants","volume":"117","author":"Uko","year":"2006","journal-title":"Pediatrics"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0378-3782(12)70014-2","article-title":"\u201cGetting to Zero\u201d: Preventing Invasive Candida Infections and Eliminating Infection-Related Mortality and Morbidity in Extremely Preterm Infants","volume":"88","author":"Kaufman","year":"2012","journal-title":"Early Hum. Dev."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1093\/infdis\/jiaa394","article-title":"Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium","volume":"222","author":"Johnson","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"ii37","DOI":"10.1093\/jac\/dkw395","article-title":"The Role of the Multidisciplinary Team in Antifungal Stewardship","volume":"71","author":"Agrawal","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Mendoza-Palomar, N., Garcia-Palop, B., Melendo, S., Mart\u00edn, M.T., Renedo-Mir\u00f3, B., Soler-Palacin, P., and Fern\u00e1ndez-Polo, A. (2021). Antifungal Stewardship in a Tertiary Care Paediatric Hospital: The PROAFUNGI Study. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-05774-9"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/1\/73\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T11:54:25Z","timestamp":1767959665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/1\/73"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":159,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["antibiotics15010073"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15010073","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}